2020 NGS newsletter
2020 has been memorable, to say the least!
At Takara Bio, we want to take a moment to look back on the year. For all of the good times, for all of the bad times, we have stayed committed to developing high-quality reagents to support your next-generation sequencing needs. Here, we highlight some of the key developments we’ve had and some important contributions you have made.
January
Key publications
Dynamic MAIT cell response with progressively enhanced innateness during acute HIV-1 infection
Learn more »
February
Key publications
A new coronavirus associated with human respiratory disease in China
Learn more »
March
Key publications
Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape
Learn more »
April
Key publications
Comparison of commercially available whole-genome sequencing kits for variant detection in circulating cell-free DNA
Learn more »
May
Key publications
Single-cell analysis of murine fibroblasts identifies neonatal to adult switching that regulates cardiomyocyte maturation
Learn more »
Genomic epidemiology of SARS-CoV-2 in Guangdong Province, China
Learn more »
Distinct transcriptomic cell types and neural circuits of the subiculum and prosubiculum along the dorsal-ventral axis
Learn more »
June
Key publications
Complete genome sequence of a SARS-CoV-2 strain isolated in Northern Germany
Learn more »
August
Key publications
Validation of a combined transcriptome and T cell receptor alpha/beta (TRA/TRB) repertoire assay at the single cell level for paucicellular samples
Learn more »
September
Key publications
Benchmarking of T cell receptor repertoire profiling methods reveals large systematic biases
Learn more »
October
November
Key publications
Integrated morphoelectric and transcriptomic classification of cortical GABAergic cells
Learn more »
Single-nuclei RNA-sequencing of plants
Learn more »
In 2021, we are looking forward to new discoveries, technologies, and applications—starting with our expansion of the ThruPLEX lineup next month. We're also moving to a new, larger headquarters so we may continue to grow and provide best-in-class products to you. Thank you for your persistence in 2020, and we can’t wait to work with you in the lab again soon!
Streamlined DNA-seq from challenging samples
Get improved coverage and mutation detection from challenging sample types, regardless of GC content.
Highest sensitivity for single-cell mRNA-seq
View data on the SMART-Seq Single Cell Kit's superior sensitivity and reproducibility for single-cell and nuclei applications.
DNA-seq for FFPE and cell-free DNA
Reliable and consistent data from difficult samples using a streamlined workflow and molecular tags for error correction.
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2022 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.
